Josie Montegaard, NP

Josie Montegaard, NP, of the Dana-Farber Cancer Institute, has extensive expertise in chronic lymphocytic leukemia.

Disclosure: Josie Montegaard, NP, has disclosed the following financial relationships: consulting for AbbVie, AstraZeneca, and BeiGene.

Articles by Josie Montegaard, NP

Josie Montegaard, NPLeukemia | April 3, 2025

Josie Montegaard, NP, shares how nurses can help patients mitigate and manage negative CLL treatment side effects.

Josie Montegaard, NPLeukemia | March 14, 2025

Josie Montegaard, NP, discusses key guidelines, criteria, and the need for flexibility when initiating treatment for CLL.

Josie Montegaard, NPLeukemia | February 28, 2025

Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.

Josie Montegaard, NPConferences | November 19, 2024

Josie Montegaard, NP, shares highlights and reflects on the importance of attending JADPRO Live, the Annual APSHO Meeting.

Cecilia BrownConferences | November 15, 2023

Josie Montegaard, NP, who spoke about CLL at JADPRO Live 2023, discusses how she hopes to see the field move forward.

Cecilia BrownConferences | November 15, 2023

Speakers from a JADPRO Live session on CLL outline what providers need to know about personalizing therapy for CLL.

Cecilia BrownHematology & Blood Cancer | February 8, 2024

Amber Koehler, MPAS, PA-C, and Josie Montegaard, NP, shared their insights during JADPRO Live, the Annual APSHO Meeting.